Mach7 Technologies (ASX:M7T) FFO


ASX:M7T Mach7 Technologies Ltd ASX:M7T
35 GF Score
Price A$0.31
GF Value A$0.82
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Mach7 Technologies FFO?

FFO (Funds from operations) only applies to REITs.

ASX:M7T
35GF Score
Mach7 Technologies Ltd ASX:M7T
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Mach7 Technologies (ASX:M7T) Overvalued in 2026?

Based on GuruFocus' analysis, Mach7 Technologies stock appears to be undervalued. The current stock price of A$0.31 is trading 62.8% below its estimated GF Value™ of A$0.82. GuruFocus considers Mach7 Technologies to be Possible Value Trap.

Key valuation signals for ASX:M7T:

  • FFO:
  • GF Value™: A$0.82 vs. price of A$0.31 (62.8% below fair value)
  • GF Score™: 35/100 with 3 warning signs

No single metric tells the full story. See the ASX:M7T stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Mach7 Technologies Business Description

Other Exchanges TDMMF:USA
Address 120 Kimball Avenue, Suite 210, South Burlington, VT, USA, 05403
Mach7 Technologies Ltd is a healthcare software company focused on enterprise imaging infrastructure. The company's vendor neutral platform enables health systems to manage, access, and exchange medical imaging data across departments, sites, and vendors. It serves across North America, Asia-Pacific, and the Middle East, with deployments ranging from academic medical centres to multi-site health networks. A substantial part of revenue is derived in the form of Subscription revenue. Geographically, it derives a majority of its revenue from North America.
35GF Score

Get the complete analysis for ASX:M7T

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

A$0.31
Price
A$0.82
GF Value